Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.

S J DeNardo; P A Burke; B R Leigh; R T O'Donnell; L A Miers; L A Kroger; S L Goodman; S Matzku; A Jonczyk; K R Lamborn

doi:10.1089/cbr.2000.15.71

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.

Identifier:nobleid.org/w1/20260515/BC89DF21

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BC89DF21.svg?ark=w1%2F20260515%2FBC89DF21)](https://nobleid.org/work/w1/20260515/BC89DF21)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.

Identifier:nobleid.org/w1/20260515/BC89DF21

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BC89DF21.svg?ark=w1%2F20260515%2FBC89DF21)](https://nobleid.org/work/w1/20260515/BC89DF21)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work